世界の遺伝性血管性浮腫治療市場は、2022年には約44億2,000万米ドルと評価され、予測期間の2023年から2030年には8.5%以上の健全な成長率で成長すると予測されている。遺伝性血管浮腫は、顔、喉、四肢、腹部など、体のさまざまな部分に再発性の腫れを引き起こす稀な遺伝性疾患です。これらの発作が気道に関わる場合、重篤で生命を脅かす可能性があります。遺伝性血管浮腫治療市場は、遺伝性疾患の有病率の上昇や新しい治療法の採用増加などの要因により拡大しています。アンドロゲンは、C1阻害薬の産生を増加させ、HAE発作の頻度と重症度を減少させるホルモンです。しかし、女性や小児の男性化、肝毒性、血栓リスクの増加などの重大な副作用があります。HAEの有病率はここ数十年の間に徐々に増加しています。
世界保健機関（WHO）によると、遺伝性疾患や先天性異常は出生児の約2％〜5％にみられ、小児科入院の最大30％を占め、先進国では小児死亡の約50％を引き起こしています。さらに、Statistaによると、2020年にヨーロッパが実施した調査では、イギリスの回答者の36％が、遺伝性疾患への傾向において遺伝が果たす重要性を認識していないことが判明しまし。この分野を牽引するもう一つの重要な要素は、新規治療薬の採用が増加していることです。Statista によると、世界で最も支出されると予測される治療分野は腫瘍学で約3,770億ドルで、次いで免疫学が約1,770億ドルの支出となると予測されています。 さらに、2022年には、Wave Life Sciences Ltd社は、Wave社の前臨床 RNA 編集プログラムを含む、オリゴヌクレオチド治療薬を進歩させるための戦略的提携を結びました。創薬協力の最初の研究期間は4年間です。GSK社の独自のヒト遺伝的洞察とその世界的な開発および商業能力は、Wave社の特許取得済みの創薬および医薬品開発プラットフォームである PRISMTM と組み合わされています。また、血管性浮腫に関連する薬剤の製剤化と技術進歩は、予測期間を通じて市場に有利な成長見通しを生み出すでしょう。しかし、遺伝性血管性浮腫治療薬に関する認知度の低さが、2023年から2030年の予測期間を通じて市場の成長を阻害しています。
世界の遺伝性血管性浮腫治療薬市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東およびアフリカが含まれます。2022年の市場は、主要市場プレイヤーの存在により北アメリカが優位を占めています。Statistaによると、北アメリカは2020年に世界の細胞・遺伝子治療産業の約56%を占め、2021年から2027年にかけて33.8%の割合で増加すると予想されています。アジア太平洋地域は、老年人口や対象人口の増加、政府機関や非営利団体の市場参入などの要因により、予測期間中に大きく成長する見込みです。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Hereditary Angioedema Therapeutic Market, by Region, 2020-2030 (USD Billion)
1.2.2. Hereditary Angioedema Therapeutic Market, by Drug Class, 2020-2030 (USD Billion)
1.2.3. Hereditary Angioedema Therapeutic Market, by Treatment Type, 2020-2030 (USD Billion)
1.2.4. Hereditary Angioedema Therapeutic Market, by Route of Administration, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Hereditary Angioedema Therapeutic Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Hereditary Angioedema Therapeutic Market Dynamics
3.1. Hereditary Angioedema Therapeutic Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of genetic disorders
3.1.1.2. Increasing adoption of novel therapeutics
3.1.2. Market Challenges
3.1.2.1. Lack of awareness about Hereditary Angioedema Therapeutic
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation
3.1.3.2. Technological advancement in drugs related to Angioedema
Chapter 4. Global Hereditary Angioedema Therapeutic Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Hereditary Angioedema Therapeutic Market, by Drug Class
5.1. Market Snapshot
5.2. Global Hereditary Angioedema Therapeutic Market by Drug Class, Performance - Potential Analysis
5.3. Global Hereditary Angioedema Therapeutic Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
5.4. Hereditary Angioedema Therapeutic Market, Sub Segment Analysis
5.4.1. C1-esterase inhibitor
5.4.2. Bradykinin B2 receptor antagonist
5.4.3. Kallikrein inhibitor
5.4.4. Others
Chapter 6. Global Hereditary Angioedema Therapeutic Market, by Treatment Type
6.1. Market Snapshot
6.2. Global Hereditary Angioedema Therapeutic Market by Treatment Type, Performance - Potential Analysis
6.3. Global Hereditary Angioedema Therapeutic Market Estimates & Forecasts by Treatment Type 2020-2030 (USD Billion)
6.4. Hereditary Angioedema Therapeutic Market, Sub Segment Analysis
6.4.1. Prophylaxis
6.4.2. On-demand
Chapter 7. Global Hereditary Angioedema Therapeutic Market, by Route of Administration
7.1. Market Snapshot
7.2. Global Hereditary Angioedema Therapeutic Market by Route of Administration, Performance - Potential Analysis
7.3. Global Hereditary Angioedema Therapeutic Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
7.4. Hereditary Angioedema Therapeutic Market, Sub Segment Analysis
7.4.1. Intravenous
7.4.2. Subcutaneous
7.4.3. Oral
Chapter 8. Global Hereditary Angioedema Therapeutic Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Hereditary Angioedema Therapeutic Market, Regional Market Snapshot
8.4. North America Hereditary Angioedema Therapeutic Market
8.4.1. U.S. Hereditary Angioedema Therapeutic Market
8.4.1.1. Drug Class breakdown estimates & forecasts, 2020-2030
8.4.1.2. Treatment Type breakdown estimates & forecasts, 2020-2030
8.4.1.3. Route of Administration breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Hereditary Angioedema Therapeutic Market
8.5. Europe Hereditary Angioedema Therapeutic Market Snapshot
8.5.1. U.K. Hereditary Angioedema Therapeutic Market
8.5.2. Germany Hereditary Angioedema Therapeutic Market
8.5.3. France Hereditary Angioedema Therapeutic Market
8.5.4. Spain Hereditary Angioedema Therapeutic Market
8.5.5. Italy Hereditary Angioedema Therapeutic Market
8.5.6. Rest of Europe Hereditary Angioedema Therapeutic Market
8.6. Asia-Pacific Hereditary Angioedema Therapeutic Market Snapshot
8.6.1. China Hereditary Angioedema Therapeutic Market
8.6.2. India Hereditary Angioedema Therapeutic Market
8.6.3. Japan Hereditary Angioedema Therapeutic Market
8.6.4. Australia Hereditary Angioedema Therapeutic Market
8.6.5. South Korea Hereditary Angioedema Therapeutic Market
8.6.6. Rest of Asia Pacific Hereditary Angioedema Therapeutic Market
8.7. Latin America Hereditary Angioedema Therapeutic Market Snapshot
8.7.1. Brazil Hereditary Angioedema Therapeutic Market
8.7.2. Mexico Hereditary Angioedema Therapeutic Market
8.8. Middle East & Africa Hereditary Angioedema Therapeutic Market
8.8.1. Saudi Arabia Hereditary Angioedema Therapeutic Market
8.8.2. South Africa Hereditary Angioedema Therapeutic Market
8.8.3. Rest of Middle East & Africa Hereditary Angioedema Therapeutic Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. CSL Limited
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Takeda Pharmaceutical Company Limited
9.3.3. Pharming Healthcare Inc
9.3.4. Sanofi S.A.
9.3.5. BioCryst Pharmaceuticals Inc
9.3.6. Ionis Pharmaceuticals, Inc
9.3.7. Shire Plc
9.3.8. Attune Pharmaceuticals, Inc
9.3.9. Adverum Biotechnologies, Inc
9.3.10. KalVista Pharmaceuticals, Inc
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
List of Tables
TABLE 1. Global Hereditary Angioedema Therapeutic Market, report scope
TABLE 2. Global Hereditary Angioedema Therapeutic Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Hereditary Angioedema Therapeutic Market estimates & forecasts by Drug Class 2020-2030 (USD Billion)
TABLE 4. Global Hereditary Angioedema Therapeutic Market estimates & forecasts by Treatment Type 2020-2030 (USD Billion)
TABLE 5. Global Hereditary Angioedema Therapeutic Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
TABLE 6. Global Hereditary Angioedema Therapeutic Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Hereditary Angioedema Therapeutic Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Hereditary Angioedema Therapeutic Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Hereditary Angioedema Therapeutic Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Hereditary Angioedema Therapeutic Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Hereditary Angioedema Therapeutic Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Hereditary Angioedema Therapeutic Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Hereditary Angioedema Therapeutic Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Hereditary Angioedema Therapeutic Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Hereditary Angioedema Therapeutic Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Hereditary Angioedema Therapeutic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Hereditary Angioedema Therapeutic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Hereditary Angioedema Therapeutic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Hereditary Angioedema Therapeutic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Hereditary Angioedema Therapeutic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Hereditary Angioedema Therapeutic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Hereditary Angioedema Therapeutic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Hereditary Angioedema Therapeutic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Hereditary Angioedema Therapeutic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Hereditary Angioedema Therapeutic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Hereditary Angioedema Therapeutic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Hereditary Angioedema Therapeutic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Hereditary Angioedema Therapeutic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Hereditary Angioedema Therapeutic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Hereditary Angioedema Therapeutic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Hereditary Angioedema Therapeutic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Hereditary Angioedema Therapeutic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Hereditary Angioedema Therapeutic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Hereditary Angioedema Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Hereditary Angioedema Therapeutic Market
TABLE 71. List of primary sources, used in the study of global Hereditary Angioedema Therapeutic Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Hereditary Angioedema Therapeutic Market, research methodology
FIG 2. Global Hereditary Angioedema Therapeutic Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Hereditary Angioedema Therapeutic Market, key trends 2022
FIG 5. Global Hereditary Angioedema Therapeutic Market, growth prospects 2023-2030
FIG 6. Global Hereditary Angioedema Therapeutic Market, porters 5 force model
FIG 7. Global Hereditary Angioedema Therapeutic Market, pest analysis
FIG 8. Global Hereditary Angioedema Therapeutic Market, value chain analysis
FIG 9. Global Hereditary Angioedema Therapeutic Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Hereditary Angioedema Therapeutic Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Hereditary Angioedema Therapeutic Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Hereditary Angioedema Therapeutic Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Hereditary Angioedema Therapeutic Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Hereditary Angioedema Therapeutic Market, regional snapshot 2020 & 2030
FIG 15. North America Hereditary Angioedema Therapeutic Market 2020 & 2030 (USD Billion)
FIG 16. Europe Hereditary Angioedema Therapeutic Market 2020 & 2030 (USD Billion)
FIG 17. Asia Pacific Hereditary Angioedema Therapeutic Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Hereditary Angioedema Therapeutic Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Hereditary Angioedema Therapeutic Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
